APYX
Apyx MedicalBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-03
Current thesis
The strongest post-earnings evidence is internal rather than Street-driven: Q1 revenue grew 32.4%, Surgical Aesthetics grew 36.1%, gross margin improved, adjusted EBITDA loss narrowed, and management raised FY2026 revenue guidance to $59.0 million-$60.0 million while citing strong AYON adoption and better-than-expected international demand, including South Korea [#8-K-2026-05-07].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
AYON's planned power-liposuction label expansion is still awaiting the anticipated second-quarter 2026 FDA clearance, so a delay would remove a key near-term catalyst [#10-Q-2026-05-07].
Momentum
87
Value
36
Sentiment
46
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.10 · Bull $5.25 · Bear $2.40
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-03
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $6.00
Why
Momentum87 · Δ7d -
Value36 · Δ7d -0.0
Sentiment46 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
87
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
46
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 87.1 / Value 36.3 / Sentiment 46.2
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$161.22M
Beta
1.59
Shares Out
41.01M
P/E (TTM) · Derived
-6.0
P/S (TTM)
3.03
P/FCF (TTM) · Derived
-16.61
Rev YoY
+12.1%
EPS YoY
+64.1%
Gross Margin
+62.6%
Op Margin
-19.8%
Net Debt
$2.21M
Current Ratio
4.44
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology